CD8A and neoplasm: Further validating the direct effect of APR-246 treatment on tumor antigenicity, BMDCs loaded with MQ- versus vehicle-treated B16 tumor cells enhanced the priming of cocultured pmel CD8+ T cells by increasing their proliferation and activation (Figs 4F and G and S3D and E left panels).